Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 12(2): e0172652, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28245252

RESUMO

The worldwide dissemination of extended-spectrum beta-lactamase producing Enterobacteriaceae, (ESBL-E) and their subset producing carbapenemases (CPE), is alarming. Limited data on the prevalence of such strains in infections from patients from Sub-Saharan Africa are currently available. We determined, here, the prevalence of ESBL-E/CPE in bacteriemic patients in two teaching hospitals from Bamako (Mali), which are at the top of the health care pyramid in the country. During one year, all Enterobacteriaceae isolated from bloodstream infections (E-BSI), were collected from patients hospitalized at the Point G University Teaching Hospital and the pediatric units of Gabriel Touré University Teaching Hospital. Antibiotic susceptibility testing, enzyme characterization and strain relatedness were determined. A total of 77 patients had an E-BSI and as many as 48 (62.3%) were infected with an ESBL-E. ESBL-E BSI were associated with a previous hospitalization (OR 3.97 95% IC [1.32; 13.21]) and were more frequent in hospital-acquired episodes (OR 3.66 95% IC [1.07; 13.38]). Among the 82 isolated Enterobacteriaceae, 58.5% were ESBL-E (20/31 Escherichia coli, 20/26 Klebsiella pneumoniae and 8/15 Enterobacter cloacae). The remaining (5 Salmonella Enteritidis, 3 Morganella morganii 1 Proteus mirabilis and 1 Leclercia adecarboxylata) were ESBL negative. CTX-M-1 group enzymes were highly prevalent (89.6%) among ESBLs; the remaining ones being SHV. One E. coli produced an OXA-181 carbapenemase, which is the first CPE described in Mali. The analysis of ESBL-E relatedness suggested a high rate of cross transmission between patients. In conclusion, even if CPE are still rare for the moment, the high rate of ESBL-BSI and frequent cross transmission probably impose a high medical and economic burden to Malian hospitals.


Assuntos
Bacteriemia/microbiologia , Enterobacteriaceae/enzimologia , beta-Lactamases/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/farmacologia , Farmacorresistência Bacteriana , Enterobacter cloacae/efeitos dos fármacos , Enterobacter cloacae/fisiologia , Enterobacteriaceae/efeitos dos fármacos , Enterobacteriaceae/isolamento & purificação , Enterobacteriaceae/fisiologia , Escherichia coli/efeitos dos fármacos , Escherichia coli/fisiologia , Feminino , Hospitais de Ensino/estatística & dados numéricos , Humanos , Klebsiella pneumoniae/efeitos dos fármacos , Klebsiella pneumoniae/fisiologia , Masculino , Mali , Pessoa de Meia-Idade , Morganella morganii/efeitos dos fármacos , Morganella morganii/fisiologia , Prevalência , Estudos Prospectivos , Adulto Jovem
2.
Int J Infect Dis ; 50: 44-7, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27495005

RESUMO

A case of chronic osteomyelitis probably caused by Morganella morganii, occurring over a period of 30 years, is reported. The organism was identified through a combination of sample culture, direct sequencing, and 16S RNA gene amplicon sequencing. Further whole-genome sequencing and population structure analysis of the isolates from the patient showed the bacterial population to be highly diverse. This case provides a valuable example of a long-term infection caused by an opportunistic pathogen, M. morganii, with high diversity, which might evolve during replication within the host.


Assuntos
Infecções por Enterobacteriaceae/microbiologia , Morganella morganii/isolamento & purificação , Osteomielite/microbiologia , Adulto , Biodiversidade , Humanos , Masculino , Morganella morganii/classificação , Morganella morganii/genética , Morganella morganii/fisiologia , Filogenia
3.
Int J Infect Dis ; 50: 10-7, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27421818

RESUMO

Morganella morganii belongs to the tribe Proteeae of the Enterobacteriaceae family. This species is considered as an unusual opportunistic pathogen that mainly causes post-operative wound and urinary tract infections. However, certain clinical M. morganii isolates present resistance to multiple antibiotics by carrying various resistant genes (such as blaNDM-1, and qnrD1), thereby posing a serious challenge for clinical infection control. Moreover, virulence evolution makes M. morganii an important pathogen. Accumulated data have demonstrated that M. morganii can cause various infections, such as sepsis, abscess, purple urine bag syndrome, chorioamnionitis, and cellulitis. This bacterium often results in a high mortality rate in patients with some infections. M. morganii is considered as a non-negligent opportunistic pathogen because of the increased levels of resistance and virulence. In this review, we summarized the epidemiology of M. morganii, particularly on its resistance profile and resistant genes, as well as the disease spectrum and risk factors for its infection.


Assuntos
Infecções por Enterobacteriaceae/microbiologia , Morganella morganii/fisiologia , Antibacterianos/uso terapêutico , Farmacorresistência Bacteriana , Infecções por Enterobacteriaceae/tratamento farmacológico , Humanos , Morganella morganii/efeitos dos fármacos , Morganella morganii/genética , Infecções Urinárias/tratamento farmacológico , Infecções Urinárias/microbiologia
4.
Artigo em Russo | MEDLINE | ID: mdl-19459471

RESUMO

AIM: To study variability of enzymatic apparatus of opportunistic enterobacteria. MATERIALS AND METHODS: Clinical strains of Morganella morganii, Citrobacter freundii, Proteus mirabilis isolated from patients treated in Irkutsk Regional Hospital for Infectious Diseases. Activity of cellulase and lipase as well as amount of auxins and gibberellins was studied in these bacteria at different cultivation temperatures. RESULTS: It was shown that studied species isolated from humans enterobacteria are able to produce plant growth regulators amount of which depends from cultivation temperature and type of microorganism. Activity of cellulase sharply rises if temperature falls. CONCLUSION: Obtained results show high adaptation potential of opportunistic bacteria from Enterobacteriaceae family. Switch on saprophytic mechanism after fall of temperature to environment-corresponding values allows them to survive in soil and arrange different interactions with soil biota including plants.


Assuntos
Adaptação Fisiológica , Citrobacter freundii/fisiologia , Morganella morganii/fisiologia , Proteus mirabilis/fisiologia , Celulase/biossíntese , Citrobacter freundii/metabolismo , Citrobacter freundii/patogenicidade , Giberelinas/metabolismo , Humanos , Ácidos Indolacéticos/metabolismo , Lipase/metabolismo , Morganella morganii/metabolismo , Morganella morganii/patogenicidade , Proteus mirabilis/metabolismo , Proteus mirabilis/patogenicidade , Temperatura
5.
J Laparoendosc Adv Surg Tech A ; 16(4): 404-10, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16968194

RESUMO

BACKGROUND: The purpose of this study was to evaluate the effects of elevated intra-abdominal pressure (IAP) on intestinal structures and bacterial translocation in the rat. MATERIALS AND METHODS: Forty-two male Sprague-Dawley rats were randomly divided into three experimental groups of 14 rats each: the sham group underwent insertion of a balloon-tipped catheter; the IAP-15 group was subjected to a 15 mm Hg pneumoperitoneum for 60 minutes; and the IAP-25 group was subjected to a 25 mm Hg pneumoperitoneum for 60 minutes. Intestinal structural changes (bowel circumference, overall bowel and mucosal weight, mucosal DNA and protein, villus height, and crypt depth) and bacterial translocation to mesenteric lymph nodes, liver, spleen, portal blood, and peripheral blood were determined 24 hours following pneumoperitoneum. RESULTS: IAP-15 and IAP-25 rats demonstrated a significant decrease in: bowel and mucosal weight in the duodenum, jejunum, and ileum; mucosal DNA and protein in the jejunum and ileum; villus height in the jejunum: and crypt depth in the jejunum and ileum compared to the sham rats. Bacterial translocation was demonstrated in 60% of IAP-15 rats and in 80% of IAP-25 rats. CONCLUSION: Elevated IAP results in mucosal injury of the gut, causing mucosal hypoplasia, and increases bacterial translocation.


Assuntos
Pressão do Ar , Translocação Bacteriana , Mucosa Intestinal/patologia , Intestino Delgado/patologia , Pneumoperitônio Artificial/efeitos adversos , Escala Resumida de Ferimentos , Animais , DNA/metabolismo , Duodeno/patologia , Enterococcus faecalis/fisiologia , Escherichia coli/fisiologia , Íleo/patologia , Mucosa Intestinal/microbiologia , Intestino Delgado/microbiologia , Jejuno/patologia , Klebsiella/fisiologia , Masculino , Modelos Animais , Morganella morganii/fisiologia , Tamanho do Órgão , Placebos , Proteínas/metabolismo , Pseudomonas/fisiologia , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Staphylococcus aureus/fisiologia
6.
Int J Antimicrob Agents ; 27(6): 505-12, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16690260

RESUMO

A multiresistant strain of Morganella morganii was isolated from a patient affected by several severe pathologies. The isolate was found to be resistant to the following antimicrobials: ampicillin, nalidixic acid, cefalothin, cefoxitin, ceftriaxone, ciprofloxacin, chloramphenicol, streptomycin, erythromycin, gentamicin, novobiocin, penicillin, rifampicin, tetracycline and violet crystal. Mechanisms leading to this multiresistance were studied. Porins of M. morganii multiresistant and wild-type strains were analysed by sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and were characterised by their ability to form channels in planar black lipid bilayers. The channels formed by porins from multiresistant and susceptible strains suggested that the porins of the multiresistant strain were not responsible for resistance. A 6.6 kb plasmid (pML2003) was detected, isolated and studied. pML2003 included two integrons. Direct sequencing revealed that one of the integrons contained two cassettes, aminoglycoside adenyltransferase (aadB) and chloramphenicol acetyltransferase (catB3) conferring resistance to aminoglycosides and chloramphenicol, respectively. The second integron contained carbenicillinase (blaP1b) and adenyltransferase (aadA2), which confer resistance to beta-lactamases and streptomycin, respectively.


Assuntos
Farmacorresistência Bacteriana Múltipla , Integrons , Morganella morganii/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Morganella morganii/genética , Morganella morganii/fisiologia , Plasmídeos , Porinas/isolamento & purificação , Porinas/fisiologia , Cloreto de Potássio/farmacologia
8.
J Perinatol ; 19(7): 533-5, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10685307

RESUMO

OBJECTIVE: This paper reports a case of chorioamnionitis due to Morganella morganii in a mother who presented with ruptured membranes at 24 weeks' gestation and was treated with dexamethasone and prophylactic ampicillin. Her premature infant developed severe early onset infection due to the same organism and expired. STUDY DESIGN: A clinical case report of M. morganii infection complicating preterm rupture of membranes is presented. Possible risk factors for maternal and neonatal infection with this organism as well as the therapy of neonatal M. morganii infection are discussed. RESULTS: Risk factors in the mother included having a cervical cerclage in place and treatment with dexamethasone and prophylactic ampicillin. The major risk factors in the infant were maternal chorioamnionitis and extreme prematurity. The mother responded to treatment with ampicillin, metronidazole, and gentamicin following delivery and had an uncomplicated recovery. Her infant developed severe early onset M. morganii infection complicated by neutropenia, thrombocytopenia, and severe acidosis and expired. Postmortem cultures of pleural fluid, peritoneal fluid, and blood were positive despite treatment with gentamicin, an antibiotic to which the organism was sensitive. CONCLUSION: M. morganii may cause serious infection in pregnancy and in the neonatal period. The use of dexamethasone and prophylactic ampicillin may have increased the risk of infection with this ampicillin-resistant organism. The failure of gentamicin to sterilize the infant's blood and body fluids emphasizes the necessity of treating such infections with a combination of an aminoglycoside and a third-generation cephalosporin, such as cefotaxime.


Assuntos
Infecções por Enterobacteriaceae/transmissão , Recém-Nascido de Baixo Peso , Morganella morganii , Complicações Infecciosas na Gravidez , Adulto , Ampicilina/uso terapêutico , Anti-Inflamatórios/uso terapêutico , Corioamnionite/tratamento farmacológico , Dexametasona/uso terapêutico , Infecções por Enterobacteriaceae/tratamento farmacológico , Evolução Fatal , Feminino , Ruptura Prematura de Membranas Fetais/complicações , Humanos , Recém-Nascido , Transmissão Vertical de Doenças Infecciosas , Morganella morganii/fisiologia , Resistência às Penicilinas , Penicilinas/uso terapêutico , Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...